Schedule 13D ownership disclosure
Rocket Pharmaceuticals Inc
Security class unavailable · CUSIP: 77313F106
Event date: 2023-09-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.2100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-004826
- Form type
- SC 13D
- Filer
- ROCKET PHARMACEUTICALS, INC.
- CIK
- CIK 1281895
- Filed
- Sep 19, 2023
- Reporting period
- Sep 15, 2023
- Description
- Schedule 13D beneficial ownership